T&R Biofab Co., Ltd. (KOSDAQ:246710)
South Korea · Delayed Price · Currency is KRW 3,230.00
-250.00 (-7.18%)
Jan 30, 2026, 3:30 PM KST
T&R Biofab Market Cap
T&R Biofab has a market cap or net worth of 153.65 billion as of January 30, 2026. Its market cap has increased by 62.99% in one year.
Market Cap
153.65B
Enterprise Value
196.40B
Revenue
20.67B
Ranking
n/a
PE Ratio
n/a
Stock Price
3,230.00
Market Cap Chart
Since November 28, 2018, T&R Biofab's market cap has increased from 101.48B to 153.65B, an increase of 51.41%. That is a compound annual growth rate of 5.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 29, 2026 | 165.54B | -7.66% |
| Dec 30, 2025 | 179.28B | 91.93% |
| Dec 30, 2024 | 93.41B | -51.40% |
| Dec 28, 2023 | 192.21B | -20.80% |
| Dec 29, 2022 | 242.68B | -53.25% |
| Dec 30, 2021 | 519.07B | 265.38% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Nov 28, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| DuChemBIO | 256.52B |
| CG MedTech | 152.31B |
| OSTEONIC | 128.59B |
| JW Shinyak | 113.14B |
| Sewoon Medical | 103.03B |
| SCL Science | 78.24B |
| Wonbiogen | 47.88B |
| KM Corporation | 46.39B |